Veracyte (VCYT)
(Delayed Data from NSDQ)
$22.57 USD
+1.06 (4.93%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $22.55 -0.02 (-0.09%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth B Momentum D VGM
Brokerage Reports
Veracyte, Inc. [VCYT]
Reports for Purchase
Showing records 21 - 40 ( 42 total )
Company: Veracyte, Inc.
Industry: Medical - Instruments
Gaining Clarity with 2Q Volume/ Decipher Comparisons
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Continued Return to Growth and Upbeat Outlook
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Decipher and Molecular Dx Clarity with 3Q
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
ASCO Annual Meeting: Compelling Picture of Molecular Diagnostic Future
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Too Much Transition News; Valuation Becoming Interesting
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Diverse Molecular Diagnostic Portfolio Gaining Momentum
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Healthcare 2021 Outlook: From Lab to Clinic To Patient the Transformation of Healthcare Continues
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Updates Following Analyst Day; New FY23E and FY21E Quarters
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Initiating Coverage on Life Science Technology, Bioproduction, - Diagnostics
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department